Considering that models incorporating data on health changes leading up to pancreatic cancer diagnosis performed better than the PanScan model that relied on data on static etiologic risk factors and ABO genotypes [35] suggests that models based on such etiologic risk factors do not well identify exactly when such factors should operate, compared to prediction models based on changes in health. This evidence concerns the gene ABO and pancreatic neoplasm.